Our Contract Research Service Division works with a strong focus on genomics and molecular biology techniques to offer services meeting the customer requirements. We execute R&D projects of economic significance for private-sector pharmaceutical Companies, Biotech Companies as well as Government organizations.
At geneOmbio our goal is to be a true partner for our clients, so we can assist them to reach their goals as quickly and economically as possible while maintaining the highest standards of quality for our services.
Our Molecular Diagnostic Division has Pathogen detection tests for HIV, TB, Hepatitis, and various other bacterial and viral infections. We perform molecular disease detection tests based on gene mutations and chromosome alterations. We offer tests for molecular diagnosis of cancer and metabolic disorders. These services are offered to clinics, Diagnostics chains & centers, Pathology labs, Hospitals as well as Direct patients. During the COVID19 pandemic, geneOmbio developed RNA extraction and VTM kits and subsequently received ICMR approval for these kits.
Our Nutrigenomics Division known as “GeneSupport” focuses on testing, data analysis & research towards the interaction of individual genes with nutrition and has successful associations with Dietitians, Nutritionists, Doctors, Medical Chains, and Fitness Centres as well as direct clients.
Our kits helped in the testing of more than 2 lakh patients, whereas geneOmbio as a NABL accredited and ICMR approved lab itself tested more than 60 thousand COVID19 samples.